Abstract
Human zygote arrest during in vitro culture is rare and the etiology is unclear. The oocyte-specific gene Zar1 plays an essential role in oocyte-embryo transition, and most embryos from Zar1 knockout female mice arrest at the one-cell stage. This study investigates whether maternal ZAR1 gene variations play a role in human zygote arrest. Sequence analysis of ZAR1 was conducted for 47 women with recurrent uncleaved zygotes in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles (≥ 70% zygotes uncleaved in at least 2 cycles), 93 women from IVF/ICSI cycles with normal uncleaved rate and live birth (control subset I) and 188 women with spontaneous pregnancy and live birth (control subset II). One novel synonymous variation (c.516C>T) and one novel intron variation (c.964-55A>T) of ZAR1 were identified in the zygote arrest group but not in any of the 188 controls. However, the bioinformatics analysis revealed that neither of the mutations in ZAR1 has effect on ZAR1 protein function. Compared with control subset I, the allele frequencies of rare SNPs rs117545505 and rs17609740 were significantly different in patients with zygote arrest (P = 0.047, OR = 3.66). Allele frequencies of these two SNPs were also significantly different between the case group and control subset II (P = 0.024, OR = 3.28). In conclusion, two SNPs in ZAR1 are associated with human zygote arrest, although additional proof is needed for validation.
Similar content being viewed by others
Data Availability
All data generated in this study are included in this manuscript.
References
Hardy K, Spanos S, Becker D, Iannelli P, Winston RM, Stark J. From cell death to embryo arrest: mathematical models of human preimplantation embryo development. Proc Natl Acad Sci U S A. 2001;98(4):1655–60. https://doi.org/10.1073/pnas.98.4.1655.
Zamora RB, Sanchez RV, Perez JG, Diaz RR, Quintana DB, Bethencourt JC. Human zygote morphological indicators of higher rate of arrest at the first cleavage stage. Zygote. 2011;19(4):339–44. https://doi.org/10.1017/S0967199410000407.
Sadowy S, Tomkin G, Munne S, Ferrara-Congedo T, Cohen J. Impaired development of zygotes with uneven pronuclear size. Zygote. 1998;6(2):137–41.
Papadopoulos G, Randall J, Templeton AA. The frequency of chromosome anomalies in human unfertilized oocytes and uncleaved zygotes after insemination in vitro. Hum Reprod. 1989;4(5):568–73.
Benkhalifa M, Kahraman S, Caserta D, Domez E, Qumsiyeh MB. Morphological and cytogenetic analysis of intact oocytes and blocked zygotes. Prenat Diagn. 2003;23(5):397–404. https://doi.org/10.1002/pd.606.
Rawe VY, Olmedo SB, Nodar FN, Ponzio R, Sutovsky P. Abnormal assembly of annulate lamellae and nuclear pore complexes coincides with fertilization arrest at the pronuclear stage of human zygotic development. Hum Reprod. 2003;18(3):576–82.
Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM. Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat Genet. 2003;33(2):187–91. https://doi.org/10.1038/ng1079.
Zheng P, Dean J. Oocyte-specific genes affect folliculogenesis, fertilization, and early development. Semin Reprod Med. 2007;25(4):243–51. https://doi.org/10.1055/s-2007-980218.
Wu X, Wang P, Brown CA, Zilinski CA, Matzuk MM. Zygote arrest 1 (Zar1) is an evolutionarily conserved gene expressed in vertebrate ovaries. Biol Reprod. 2003;69(3):861–7. https://doi.org/10.1095/biolreprod.103.016022.
Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol. 2009;578:23–39. https://doi.org/10.1007/978-1-60327-411-1_2.
Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12(10):683–91. https://doi.org/10.1038/nrg3051.
Sartorius LJ, Weinberger DR, Hyde TM, Harrison PJ, Kleinman JE, Lipska BK. Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. Neuropsychopharmacology. 2008;33(11):2626–34. https://doi.org/10.1038/sj.npp.1301669.
Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008;40(6):695–701. https://doi.org/10.1038/ng.f.136.
Duan J, Shi J, Fiorentino A, Leites C, Chen X, Moy W, et al. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. Am J Hum Genet. 2014;95(6):744–53. https://doi.org/10.1016/j.ajhg.2014.11.001.
Jha AN, Singh VK, Singh R, Pati SS, Patra PK, Singh L, et al. A rare non-synonymous c.102C>G SNP in the IFNB1 gene might be a risk factor for cerebral malaria in Indian populations. Infect Genet Evol. 2013;14:369–74. https://doi.org/10.1016/j.meegid.2012.12.029.
Valente AX, Shin JH, Sarkar A, Gao Y. Rare coding SNP in DZIP1 gene associated with late-onset sporadic Parkinson’s disease. Sci Rep. 2012;2:256. https://doi.org/10.1038/srep00256.
Kalnina I, Kapa I, Pirags V, Ignatovica V, Schioth HB, Klovins J. Association between a rare SNP in the second intron of human Agouti related protein gene and increased BMI. BMC Med Genet. 2009;10:63. https://doi.org/10.1186/1471-2350-10-63.
Marioni RE, Penke L, Davies G, Huffman JE, Hayward C, Deary IJ. The total burden of rare, non-synonymous exome genetic variants is not associated with childhood or late-life cognitive ability. Proc Biol Sci. 2014;281(1781):20140117. https://doi.org/10.1098/rspb.2014.0117.
Locke JM, Lango Allen H, Harries LW. A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells. Acta Diabetol. 2014;51(2):325–9. https://doi.org/10.1007/s00592-013-0499-1.
Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT. A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease. BJU Int. 2015;115(1):101–5. https://doi.org/10.1111/bju.12847.
Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008;82(1):100–12. https://doi.org/10.1016/j.ajhg.2007.09.006.
Wong GK, Yang Z, Passey DA, Kibukawa M, Paddock M, Liu CR, et al. A population threshold for functional polymorphisms. Genome Res. 2003;13(8):1873–9. https://doi.org/10.1101/gr.1324303.
Shinojima Y, Terui T, Hara H, Kimura M, Igarashi J, Wang X, et al. Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation. J Dermatol Sci. 2010;59(2):98–106. https://doi.org/10.1016/j.jdermsci.2010.04.016.
Watanabe T, Yachi K, Ohta T, Fukushima T, Yoshino A, Katayama Y, et al. Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors. Brain Tumor Pathol. 2011;28(3):199–202. https://doi.org/10.1007/s10014-011-0019-3.
Watanabe T, Yachi K, Ohta T, Fukushima T, Yoshino A, Katayama Y, et al. Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors. Neurol Med Chir. 2010;50(12):1062–9.
Takagi K, Fujiwara K, Takayama T, Mamiya T, Soma M, Nagase H. DNA hypermethylation of in hepatitis C virus positive related hepatocellular carcinoma. SpringerPlus. 2013;2(1):150. https://doi.org/10.1186/2193-1801-2-150.
Sugito K, Kawashima H, Yoshizawa S, Uekusa S, Hoshi R, Furuya T, et al. Non-promoter DNA hypermethylation of Zygote Arrest 1 (ZAR1) in neuroblastomas. J Pediatr Surg. 2013;48(4):782–8. https://doi.org/10.1016/j.jpedsurg.2012.08.008.
Brebi P, Hoffstetter R, Andana A, Ili CG, Saavedra K, Viscarra T, et al. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I. Biomarkers. 2014;19(3):181–8. https://doi.org/10.3109/1354750X.2013.867535.
Acknowledgments
The authors thank all the women subjects who participated in this study.
Funding
This research was supported by the National Key Research and Development Program of China (2017YFC1001000, 2016YFC1000600); the National Natural Science Foundation of China (81430029, 81701410, 81622021, 31871509, 31571548, 31601199); the National Natural Science Foundation of Shandong Province (JQ201816); and the National Institutes of Health (R01HD085527).
Author information
Authors and Affiliations
Contributions
YT and HZ partially designed, executed, and drafted the manuscript; YT, JY, and TC collected all clinical data; YP, TH, LC, and CZ collected blood samples; YT, JY, and YP performed experiments; and HZ revised the article. All authors gave their final approval of the version to be published.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Statement of Human Rights Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all participants this study.
Consent for Publication
All authors agreed for publication.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 16 kb)
Rights and permissions
About this article
Cite this article
Tian, Y., Yang, J., Peng, Y. et al. Variation Screening of Zygote Arrest 1(ZAR1) in Women with Recurrent Zygote Arrest During IVF/ICSI Programs. Reprod. Sci. 27, 2265–2270 (2020). https://doi.org/10.1007/s43032-020-00246-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-020-00246-y